BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27925179)

  • 1. Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
    Wu SM; Lin SL; Lee KY; Chuang HC; Feng PH; Cheng WL; Liao CJ; Chi HC; Lin YH; Tsai CY; Chen WJ; Yeh CT; Lin KH
    Int J Cancer; 2017 Apr; 140(7):1581-1596. PubMed ID: 27925179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition.
    Zhang Y; Wang W; Wang Y; Huang X; Zhang Z; Chen B; Xie W; Li S; Shen S; Peng B
    Oncol Rep; 2018 Mar; 39(3):1023-1033. PubMed ID: 29399700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
    Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
    Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation.
    Wen S; Liu Y; Yang M; Yang K; Huang J; Feng D
    Oncol Rep; 2016 Oct; 36(4):2193-9. PubMed ID: 27509921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of NEK2 is associated with hepatocellular carcinoma progression and poor prognosis.
    Fu L; Liu S; Wang H; Ma Y; Li L; He X; Mou X; Tong X; Hu Z; Ru G
    Cancer Biomark; 2017 Jul; 20(1):101-106. PubMed ID: 28759960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NEK2 Promotes Hepatoma Metastasis and Serves as Biomarker for High Recurrence Risk after Hepatic Resection.
    Chang YY; Yen CJ; Chan SH; Chou YW; Lee YP; Bao CY; Huang CJ; Huang W
    Ann Hepatol; 2018 Aug; 17(5):843-856. PubMed ID: 30145571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nek2 augments sorafenib resistance by regulating the ubiquitination and localization of β-catenin in hepatocellular carcinoma.
    Deng L; Sun J; Chen X; Liu L; Wu D
    J Exp Clin Cancer Res; 2019 Jul; 38(1):316. PubMed ID: 31319849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEK2 serves as a prognostic biomarker for hepatocellular carcinoma.
    Li G; Zhong Y; Shen Q; Zhou Y; Deng X; Li C; Chen J; Zhou Y; He M
    Int J Oncol; 2017 Feb; 50(2):405-413. PubMed ID: 28101574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer.
    Zeng YR; Han ZD; Wang C; Cai C; Huang YQ; Luo HW; Liu ZZ; Zhuo YJ; Dai QS; Zhao HB; Liang YX; Zhong WD
    BMC Urol; 2015 Aug; 15():90. PubMed ID: 26320076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEK2 promotes the progression of liver cancer by resisting the cellular senescence.
    Lei Q; Xia J; Feng X; Guo J; Li G; Zhou W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):153-164. PubMed ID: 35545405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
    Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M
    Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.
    Takahashi Y; Iwaya T; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Takano Y; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2014 Jan; 21(1):205-12. PubMed ID: 24046120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEK2 regulates stem-like properties and predicts poor prognosis in hepatocellular carcinoma.
    Lin S; Zhou S; Jiang S; Liu X; Wang Y; Zheng X; Zhou H; Li X; Cai X
    Oncol Rep; 2016 Aug; 36(2):853-62. PubMed ID: 27349376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway.
    Tang X; Cao T; Zhu Y; Zhang L; Chen J; Liu T; Ming X; Fang S; Yuan YF; Jiang L; Huang JD; Guan XY
    Cell Death Dis; 2020 Jul; 11(7):510. PubMed ID: 32641749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma.
    Zhu X; Wu Y; Miao X; Li C; Yin H; Yang S; Lu X; Liu Y; Chen Y; Shen R; Chen X; He S
    Tumour Biol; 2016 Nov; 37(11):14615-14628. PubMed ID: 27619678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK1 and activation of NF-κB pathway.
    Tey SK; Tse EYT; Mao X; Ko FCF; Wong AST; Lo RC; Ng IO; Yam JWP
    Cancer Lett; 2017 Dec; 411():150-161. PubMed ID: 28989054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCA3 contributes to the malignant progression of hepatocellular carcinoma through AKT activation and NF-κB translocation.
    Ma D; Li M; Su J; Zhang S
    Exp Cell Res; 2018 Jan; 362(1):142-151. PubMed ID: 29133128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.